Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Unemployment among women with multiple sclerosis: the role of coping and perceived stress and support in the workplace.
Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy.
Sleep loss as risk factor for neurologic disorders: A review.
Ginkgo biloba does not improve cognitive function in MS: A randomized placebo-controlled trial.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
Neuromyelitis optica in pregnancy complicated by posterior reversible encephalopathy syndrome, eclampsia and fetal death.
[Microglia in pathophysiology of neuroimmunological disorders].
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Neuroprotective effects of chrysin: From chemistry to medicine.
Role of Chlamydia in Multiple Sclerosis.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage.
Multiple sclerosis: from molecules to treatment.
The primary vascular dysregulation syndrome: implications for eye diseases.
Prediction of risk of fracture in the tibia due to altered bone mineral density distribution resulting from disuse: A finite element study.

Pages